2025年精神病学基因组学:最先进的技术和前进的道路
Chunyu Liu1, Chunling Zhang2, Stephen J Glatt1
1Department of Psychiatry, SUNY Upstate Medical University, 505 Irving Avenue, Syracuse, NY 13210, USA.
The Psychiatric clinics of North America
|May 10, 2025
概括
精神病学遗传学从基因研究向全基因组测序进展. 基因位置的功能解释是精密精神病学的关键,使用新技术和多样化的数据.
科学领域:
- 基因组学和精神病学研究
- 翻译神经科学是一种神经科学.
- 精准医学是一门精准的医学.
背景情况:
- 精神病学遗传学已经从候选基因研究发展到大规模的全基因组测序.
- 已经确定了与精神疾病相关的数百个遗传位置.
- 这些位置的功能解释对于在精神病学中推进翻译应用至关重要.
研究的目的:
- 讨论精神病学基因组学的成就,挑战和机遇.
- 突出复杂性和异质性在精神疾病中的作用.
- 探索精密精神病学新兴技术和分析方法的潜力.
主要方法:
- 对精神病基因组学当前和新兴技术的审查.
- 突出显示大脑表达量的特征位点 (eQTLs) 和单细胞RNA测序.
- 功能性基因组学,先进的分析方法和人工智能的整合.
主要成果:
- 在精神疾病中识别了许多与疾病相关的位置.
- 技术的进步提供了更好的时空分辨率,质量和灵敏度.
- 开发复杂的分析方法和人工智能用于数据解释.
结论:
- 识别出位点的功能解释是精神病遗传学的关键下一步.
- 新兴技术和人工智能对于理解复杂的精神疾病至关重要.
- 协作研究和多样化人口的包容性对于精确精神病学的未来至关重要.
相关概念视频
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
Diagnostic and Statistical Manual of Mental Disorders (DSM)
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...


